Export

Scandinavian Biopharma Holding AB

Financial information

The information source is the annual report of the company with business id 556787-2469

* Closing information (×1000) SEK

Fiscal year 202412 202312 (consolidated)
Number of months: 12 12
Turnover: 160,953 Revenue Up 154,382 Revenue Up
Financial expenses: 33 Revenue Up 16 Revenue Down
Earnings before taxes: 967 Revenue Up 686 Revenue Up
Total assets: 115,004 Revenue Down 124,478 Revenue Up
Current assets: 111,550 Revenue Down 121,394 Revenue Up
Current liabilities: 101,585 Revenue Down 112,604 Revenue Up
Equity capital: 13,419 Revenue Up 11,874 Revenue Down
Share capital: 253 253
Number of employees: 35 Revenue Up 30 Revenue Up

Financial ratios

Solvency: 11.7% Revenue Up 9.5% Revenue Down
Turnover per employee: 4,599 Revenue Down 5,146 Revenue Up
Profitability: 0.6% Revenue Up 0.4% Revenue Up
Return on equity (ROE): 7.2% Revenue Up 5.8% Revenue Up
Current ratio: 109.8% Revenue Up 107.8% Revenue Down
Return on assets (ROA): 0.9% Revenue Up 0.6%

Companies with similar products and services, and with detailed information

Fiscal year 202412
Number of months: 12
Turnover: 160,953
Financial expenses: 33
Earnings before taxes: 967
Total assets: 115,004
Current assets: 111,550
Current liabilities: 101,585
Equity capital: 13,419
Share capital: 253
Number of employees: 35

Financial ratios

Solvency: 11.7%
Turnover per employee: 4,599
Profitability: 0.6%
Return on equity (ROE): 7.2%
Current ratio: 109.8%
Return on assets (ROA): 0.9%